🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
Safety, tolerability and pharmacokinetic study of BIIX 1 XX in healthy male...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT02198287
Treatments Being Tested
Cat allergy is an increasingly prevalent condition, affecting 10-15% of pat...
Status
Completed
Location
Alpha Medical Research
Start Date
2009-03
Trial ID
NCT00867906
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV In...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-12-08
Trial ID
NCT03384290
The purpose of this study is to evaluate the safety and the efficacy of Gly...
Status
Completed
Location
Medicines Evaluation Unit
Start Date
2010-08
Trial ID
NCT01176903
Treatments Being Tested
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
The study purpose is to evaluate the effect of QAB149 * NVA237 vs. QAB149 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01699685
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
This study is designed to investigate if 600 mg ELB139 given orally t.i.d. ...
Status
Terminated
Location
Charité - University Clinics Berlin
Start Date
2006-05
Trial ID
NCT00322803
Treatments Being Tested